Published in Curr Mol Biol Rep on August 15, 2015
Fabrication and characterization of drug-loaded nano-hydroxyapatite/polyamide 66 scaffolds modified with carbon nanotubes and silk fibroin. Int J Nanomedicine (2016) 0.77
Concise Review: In Vitro Formation of Bone-Like Nodules Sheds Light on the Application of Stem Cells for Bone Regeneration. Stem Cells Transl Med (2016) 0.75
The Use of Adipose Tissue-Derived Progenitors in Bone Tissue Engineering - a Review. Transfus Med Hemother (2016) 0.75
Influence of biomechanical and biochemical stimulation on the proliferation and differentiation of bone marrow stromal cells seeded on polyurethane scaffolds. Exp Ther Med (2016) 0.75
The Effects of Endocrine Disruptors on Adipogenesis and Osteogenesis in Mesenchymal Stem Cells: A Review. Front Endocrinol (Lausanne) (2017) 0.75
Challenges of bone tissue engineering in orthopaedic patients. World J Orthop (2017) 0.75
The Holy Grail of Orthopedic Surgery: Mesenchymal Stem Cells-Their Current Uses and Potential Applications. Stem Cells Int (2017) 0.75
Bone marrow cells regenerate infarcted myocardium. Nature (2001) 21.24
A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell (2008) 18.18
The MSC: an injury drugstore. Cell Stem Cell (2011) 4.80
The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine. Nat Med (2013) 4.32
Mesenchymal stromal cells: new directions. Cell Stem Cell (2012) 3.50
Mesenchymal stromal cells: sensors and switchers of inflammation. Cell Stem Cell (2013) 3.01
Recombinant human BMP-2 and allograft compared with autogenous bone graft for reconstruction of diaphyseal tibial fractures with cortical defects. A randomized, controlled trial. J Bone Joint Surg Am (2006) 2.93
Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone. Nature (2014) 2.63
Endothelial Notch activity promotes angiogenesis and osteogenesis in bone. Nature (2014) 2.42
Multipotent mesenchymal stromal cells and the innate immune system. Nat Rev Immunol (2012) 2.36
Update on Wnt signaling in bone cell biology and bone disease. Gene (2011) 2.03
Sclerostin and Dickkopf-1 as therapeutic targets in bone diseases. Endocr Rev (2012) 1.82
Recombinant human bone morphogenetic protein-2: a randomized trial in open tibial fractures treated with reamed nail fixation. J Bone Joint Surg Am (2011) 1.58
"Mesenchymal" stem cells. Annu Rev Cell Dev Biol (2014) 1.32
Outcomes after a single-stage procedure for cell-based cartilage repair: a prospective clinical safety trial with 2-year follow-up. Am J Sports Med (2011) 1.29
A tissue engineering solution for segmental defect regeneration in load-bearing long bones. Sci Transl Med (2012) 1.26
Engineering the regenerative microenvironment with biomaterials. Adv Healthc Mater (2012) 1.24
Mechanisms of immune modulation by mesenchymal stromal cells and clinical translation. Curr Mol Med (2013) 1.12
Treatment of posttraumatic bone defects by the induced membrane technique. Orthop Traumatol Surg Res (2012) 1.10
Comparison of autogenous bone graft and endothermic calcium phosphate cement for defect augmentation in tibial plateau fractures. A multicenter, prospective, randomized study. J Bone Joint Surg Am (2008) 1.10
Concise review: bridging the gap: bone regeneration using skeletal stem cell-based strategies - where are we now? Stem Cells (2014) 1.05
There is no such thing as a biocompatible material. Biomaterials (2014) 1.01
A systematic review of comparative studies on bone graft alternatives for common spine fusion procedures. Eur Spine J (2013) 1.00
Hybrid grafting using bone marrow aspirate combined with porous β-tricalcium phosphate and trephine bone for lumbar posterolateral spinal fusion: a prospective, comparative study versus local bone grafting. Spine (Phila Pa 1976) (2012) 0.98
Complications associated with the use of the recombinant human bone morphogenetic proteins for posterior interbody fusions of the lumbar spine. Spine (Phila Pa 1976) (2013) 0.94
The chicken chorioallantoic membrane model in biology, medicine and bioengineering. Angiogenesis (2014) 0.94
MSCs: science and trials. Nat Med (2013) 0.91
Intravenous application of CD271-selected mesenchymal stem cells during fracture healing. J Orthop Trauma (2014) 0.90
Treatment of long bone defects and non-unions: from research to clinical practice. Cell Tissue Res (2011) 0.90
Clinical use of resorbable polymeric membranes in the treatment of bone defects. Orthop Clin North Am (2010) 0.88
Tissue engineered bone using select growth factors: A comprehensive review of animal studies and clinical translation studies in man. Eur Cell Mater (2014) 0.88
Bringing new life to damaged bone: the importance of angiogenesis in bone repair and regeneration. Bone (2014) 0.87
A new take on an old story: chick limb organ culture for skeletal niche development and regenerative medicine evaluation. Eur Cell Mater (2013) 0.87
The effect of a bioactive collagen membrane releasing PDGF or GDF-5 on bone regeneration. Biomaterials (2013) 0.87
Clay gels for the delivery of regenerative microenvironments. Adv Mater (2011) 0.86
Three-dimensional printing of rhBMP-2-loaded scaffolds with long-term delivery for enhanced bone regeneration in a rabbit diaphyseal defect. Tissue Eng Part A (2014) 0.85
The therapeutic potential of oxygen tension manipulation via hypoxia inducible factors and mimicking agents in guided bone regeneration. A review. Arch Oral Biol (2011) 0.84
Delayed minimally invasive injection of allogenic bone marrow stromal cell sheets regenerates large bone defects in an ovine preclinical animal model. Stem Cells Transl Med (2015) 0.84
Challenging Regeneration to Transform Medicine. Stem Cells Transl Med (2015) 0.84
Fabrication, vascularization and osteogenic properties of a novel synthetic biomimetic induced membrane for the treatment of large bone defects. Bone (2014) 0.83
Effect of different rhBMP-2 and TG-VEGF ratios on the formation of heterotopic bone and neovessels. Biomed Res Int (2014) 0.81
Controlled multiple growth factor delivery from bone tissue engineering scaffolds via designed affinity. Tissue Eng Part A (2013) 0.81
Ultraporous β-tricalcium phosphate alone or combined with bone marrow aspirate for benign cavitary lesions: comparison in a prospective randomized clinical trial. J Bone Joint Surg Am (2013) 0.81
TruFit Plug for Repair of Osteochondral Defects-Where Is the Evidence? Systematic Review of Literature. Cartilage (2015) 0.80
Percutaneous autologous bone marrow injection for treatment of delayed and non-union of long bone: a retrospective study of 45 cases. Biomed Mater Eng (2015) 0.79
Stem cells and bone: a historical perspective. Bone (2014) 0.79
Isolation, differentiation, and characterisation of skeletal stem cells from human bone marrow in vitro and in vivo. Methods Mol Biol (2012) 0.79
Large animal model for osteoporosis in humans: the ewe. Eur Cell Mater (2012) 0.79
The present state of treatments for articular cartilage defects in the knee. Ann R Coll Surg Engl (2012) 0.78
Hope versus hype: what can additive manufacturing realistically offer trauma and orthopedic surgery? Regen Med (2014) 0.78
Delayed post-treatment with bone marrow-derived mesenchymal stem cells is neurorestorative of striatal medium-spiny projection neurons and improves motor function after neonatal rat hypoxia-ischemia. Mol Cell Neurosci (2015) 0.77
Hydroxyapatite-Based Biomaterials vs. Autologous Bone Graft in Spinal Fusion: An in Vivo Animal Study. Spine (Phila Pa 1976) (2014) 0.76